Yale Medicine School: Three-Year Results From the Evolut Low-Risk TAVR Trial Show Promise
March 15, 2023
March 15, 2023
NEW HAVEN, Connecticut, March 15 (TNSjou) -- Yale School of Medicine issued the following news:
John K. Forrest MD, associate professor of medicine and director of the Interventional Cardiology and Structural Heart Disease programs at Yale School of Medicine, presented the three-year results from the Evolut Low-Risk Trial on March 5 at the American College of Cardiology (ACC) Annual Scientific Session. Forrest is the national co-principal investigator of the Evolut Low-Risk Trial an . . .
John K. Forrest MD, associate professor of medicine and director of the Interventional Cardiology and Structural Heart Disease programs at Yale School of Medicine, presented the three-year results from the Evolut Low-Risk Trial on March 5 at the American College of Cardiology (ACC) Annual Scientific Session. Forrest is the national co-principal investigator of the Evolut Low-Risk Trial an . . .